Xeris Biopharma Holdings (XERS) Capital Expenditures (2020 - 2021)
Xeris Biopharma Holdings (XERS) reported Capital Expenditures of $131000.0 for Q4 2021, down 41.78% on a YoY basis from $225000.0 in Q4 2020, and down 41.78% quarter-over-quarter from $225000.0 in Q4 2020.
Xeris Biopharma Holdings (XERS) Capital Expenditures (2020 - 2021) Analysis & Trends
Xeris Biopharma Holdings has reported Capital Expenditures for 2 years, with the latest figure at $131000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 8.83 Mn |
| 10 | Xeris Biopharma Holdings | 1.07 Bn | 954.87 Mn | 72.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 131,000.00 |
| Dec 31, 2021 | 131,000.00 |
| Dec 31, 2020 | 225,000.00 |
| Dec 31, 2020 | 225,000.00 |